Stockreport

MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity

MindWalk Holdings Corp.  (HYFT) 
PDF Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics marketHYFT®-dr [Read more]